XTL-152

N/A

Report date: 2025/12/19 17:36:14
NME

Base Information

Drug NameXTL-152
Drug Alias NameXTL-152XTL152
ClassificationSmall molecules
Mechanisms of ActionRas-related C3 botulinum toxin substrate 1 inhibitors
TargetsRas-related C3 botulinum toxin substrate 1
Therapy Area/IndicationsGlioblastomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKong's Pharmaceutical Co
China Registration ClassN/A

Develop Information

Active CompaniesKong's Pharmaceutical Co
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A